Literature DB >> 6473353

Metabolism of N1-acetylspermidine and N8-acetylspermidine in rats.

J Blankenship, P E Marchant.   

Abstract

Metabolism of N1-acetylspermidine and N8-acetylspermidine in rat liver and kidney was studied in vivo. N1-Acetylspermidine was metabolized primarily to putrescine while N8-acetylspermidine underwent deacetylation to yield spermidine. The rate of metabolism of these two compounds was much greater than that of spermidine. The rate of metabolism of N8-acetylspermidine exceeded that of N1-acetylspermidine in both liver and kidney. These rapid rates of metabolism could at least in part account for the low levels of these two compounds found in tissues. The differences in routes of metabolism of N1-acetylspermidine and N8-acetylspermidine may indicate differences in cellular functions of the two compounds.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6473353     DOI: 10.3181/00379727-177-41930

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  4 in total

Review 1.  Recent advances in the biochemistry of polyamines in eukaryotes.

Authors:  A E Pegg
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

2.  Thermal denaturation of mononucleosomes in the presence of spermine, spermidine, N1-acetylspermidine, N8-acetylspermidine or putrescine: implications for chromosome structure.

Authors:  J W Blankenship; J E Morgan; H R Matthews
Journal:  Mol Biol Rep       Date:  1987       Impact factor: 2.316

3.  Studies of non-metabolizable polyamines that support growth of SV-3T3 cells depleted of natural polyamines by exposure to alpha-difluoromethylornithine.

Authors:  S Nagarajan; B Ganem; A E Pegg
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

4.  Metabolic profiling of the protozoan parasite Entamoeba invadens revealed activation of unpredicted pathway during encystation.

Authors:  Ghulam Jeelani; Dan Sato; Afzal Husain; Aleyla Escueta-de Cadiz; Masahiro Sugimoto; Tomoyoshi Soga; Makoto Suematsu; Tomoyoshi Nozaki
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.